Table 4 General characteristics and standard echocardiographic parameters in patients with and without cardiovascular events during follow-up
Events (n=12) | No events (n=14) | p | |
|---|---|---|---|
Age, yrs | 60±2 | 63±4 | ns |
SBP, (mmHg) | 128±9 | 124±12 | ns |
DBP, (mmHg) | 76±10 | 73±8 | ns |
Diabetes, n (%) | 2 (16) | 1 (7) | ns |
Dyslipidemia, n (%) | 4 (33) | 6 (50) | ns |
Smoking, n (%) | 1 (8) | 1 (7) | ns |
Scl-70 antibodies, n (%) | 10 (83) | 4 (28) | 0.03 |
Serum levels of Scl-70 antibodies, U/ml | 83.9±57.6 | 17.1±41.7 | 0.047 |
LV EDV, ml | 85±7 | 82±6 | ns |
LV ESV, ml | 34±3 | 30±4 | ns |
LV EF, % | 62±3 | 65±2 | ns |
LV Mass, (g/m2) | 72.6±4.3 | 68.4±3.9 | ns |
Mitral E peak velocity, (cm/s) | 63.2±8.5 | 59.5±9.4 | ns |
Mitral A peak velocity, (cm/s) | 62.1±6.7 | 67.9±9.2 | ns |
Mitral E/A ratio | 1.0±0.1 | 0.8±0.2 | ns |
Mitral E deceleration time, (ms) | 176.4±12 | 182.7±18 | ns |
RVOT Prox, mm | 30.9±2.9 | 30.1±2.8 | ns |
RVD1, mm | 33.7±2.6 | 32.9±2.4 | ns |
TAPSE, mm | 20.9±3.1 | 21.8±2.8 | ns |
RV FAC, % | 46.3±5.8 | 47.1±5.4 | ns |
sPAP, (mmHg) | 38.5±3 | 36.4±7 | ns |